cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Mirum Pharmaceuticals Inc
4 own
3 watching
Current Price
$27.81
$-0.41
(-1.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,231.32M
52-Week High
52-Week High
35.56000
52-Week Low
52-Week Low
20.81000
Average Volume
Average Volume
0.22M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,231.32M
icon52-Week High35.56000
icon52-Week Low20.81000
iconAverage Volume0.22M
iconDividend Yield--
iconP/E Ratio--
What does the Mirum Pharmaceuticals Inc do?
Mirum Pharmaceuticals, Inc., a clinical-stage therapeutics company, develops and produces therapies for patients with cholestatic liver diseases with a focus on rare pediatric conditions. The company's lead product candidate is maralixibat, a Phase 3-ready investigational oral drug with indications, including Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC). It is also developing Volixibat, an investigational oral inhibitor of ASBT, a protein that is primarily responsible for recycling bile acids from the intestine to the liver. The company was incorporated in 2018 and is based in Foster City, California.
Read More
How much money does Mirum Pharmaceuticals Inc make?
News & Events about Mirum Pharmaceuticals Inc.
Business Wire
8 months ago
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced data presented during the European Association for the Study of the Liver (EASL) Congress 2023, taking place in Vienna, Austria. The congress presentations feature new analyses from the LIVMARLI (maralixibat) oral solution MARCH-PFIC study...
Business Wire
8 months ago
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that data from LIVMARLI (maralixibat) oral solution clinical studies evaluating patients with Alagille syndrome (ALGS) were published in Hepatology. LIVMARLI is the first and only approved treatment for cholestatic pruritus in patients with...
Business Wire
8 months ago
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on June 9, 2023, the Compensation Committee of Mirums Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 43,150 shares of common stock and 22,030 restricted stock units (RSUs) to nine new...
Business Wire
10 months ago
Mirum Pharmaceuticals, Inc. (Mirum) (Nasdaq: MIRM) today announced the pricing of its offering of $275.0 million aggregate principal amount of 4.00% convertible senior notes due 2029 (the notes) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act...
Business Wire
10 months ago
Mirum Pharmaceuticals, Inc. (Mirum) (Nasdaq: MIRM) today announced its intention to offer, subject to market and other conditions, $200.0 million aggregate principal amount of convertible senior notes due 2029 (the notes) in a private offering to qualified institutional buyers pursuant to Rule 144A...
Frequently Asked Questions
Frequently Asked Questions
What is Mirum Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Mirum Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Mirum Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Mirum Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Mirum Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Mirum Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Mirum Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Mirum Pharmaceuticals Inc?
plus_minus_icon
What percentage is Mirum Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Mirum Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$27.81
$-0.41
(-1.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00